Why the study?
Does resveratrol reduce systolic blood pressure and improve vascular relaxation in a 2K-1C rat model of renal hypertension?
Does resveratrol reduce systolic blood pressure and improve vascular relaxation in a 2K-1C rat model of renal hypertension?
Absolute Event Rate: 179.13% vs 196.66%
Resveratrol treatment reduces systolic blood pressure and improves endothelial-dependent vascular relaxation in a rat model of renovascular hypertension.
Resveratrol shows promise in renovascular hypertension models; leaves open translation to human hypertension management.
No takes yet. Share an insight, caveat, or question.
Pereira et al. (2014) studied Hypertension (n=38). Transresveratrol (RESV) vs. Water plus Tween 80 was evaluated on Systolic blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: